↓ Skip to main content

Donepezil for vascular cognitive impairment

Overview of attention for article published in Cochrane database of systematic reviews, January 2004
Altmetric Badge

Mentioned by

wikipedia
4 Wikipedia pages

Citations

dimensions_citation
171 Dimensions

Readers on

mendeley
306 Mendeley
connotea
1 Connotea
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Donepezil for vascular cognitive impairment
Published in
Cochrane database of systematic reviews, January 2004
DOI 10.1002/14651858.cd004395.pub2
Pubmed ID
Authors

Reem Malouf, Jacqueline Birks

Abstract

Vascular disease is the second commonest cause of dementia after Alzheimer's disease. There are difficulties in classifying patients with this type of cognitive impairment owing to varied clinical presentation and different types of arterial disease. There is some degree of overlap in the neuropathology of Alzheimer's and vascular dementia. Deficient cholinergic neurotransmission, a characteristic of Alzheimer's disease, has been postulated to contribute to the cognitive impairment of vascular disease of the brain. Cholinesterase inhibitors, such as donepezil, may therefore be a rational treatment.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 306 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 <1%
Japan 3 <1%
United Kingdom 1 <1%
Switzerland 1 <1%
Finland 1 <1%
Argentina 1 <1%
Unknown 296 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 45 15%
Researcher 37 12%
Student > Ph. D. Student 27 9%
Student > Bachelor 26 8%
Other 25 8%
Other 64 21%
Unknown 82 27%
Readers by discipline Count As %
Medicine and Dentistry 84 27%
Nursing and Health Professions 27 9%
Psychology 25 8%
Neuroscience 15 5%
Agricultural and Biological Sciences 13 4%
Other 47 15%
Unknown 95 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 June 2019.
All research outputs
#8,571,053
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#9,070
of 11,499 outputs
Outputs of similar age
#37,973
of 147,690 outputs
Outputs of similar age from Cochrane database of systematic reviews
#36
of 52 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 15th percentile – i.e., 15% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 147,690 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 52 others from the same source and published within six weeks on either side of this one. This one is in the 11th percentile – i.e., 11% of its contemporaries scored the same or lower than it.